Survivin基因在膀胱肿瘤中的研究进展
摘要
膀胱癌是我国最常见的泌尿系统恶性肿瘤之一,其最常见的组织学类型为移行细胞癌。目前,T2期以内肿瘤治疗手段仍然是以手术切除为主。在每年的新发病例中,大约有70%为表浅非浸润性肿瘤,手术治疗效果良好,但术后易复发,
出处
《南昌大学学报（医学版）》
CAS
2012年第3期98-100,共3页
Journal of Nanchang University：Medical Sciences
参考文献22
-
1May M,Fritsche H M,Brookaman May S. Patients with bladder cancer in clinical stage T2:survival benefit of downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens[J].Urologe Ausgabe A,2010,(12):1508-1515.
-
2Bartsch G,Mitra A P,Cote R J. Expression profiling for bladder cancer:strategies to uncover prognostic factors[J].Expert Review of Anticancer Therapy,2010,(12):1945-1954.
-
3Ambrosini G,Adida C,Altieri D C. A novel anti-apoptosis gene,survivin,expressed in cancer and lymphoma[J].Nater Med,1997,(08):917-921.doi:10.1038/nm0897-917.
-
4Romagnoli M,Séveno C,Bataille R. Survivin in cancerology:molecular aspects and therapeutic applications[J].Medical Sciences(Paris),2008,(10):821-827.
-
5Lehner R,Lucia M S,Jarboe E A. Immunohistochemical localization of the IAP protein survivin in bladder mucosa and transitional cell carcinoma[J].Appl Immunohlstochem Mol Morphol,2002,(02):134-138.
-
6Gazzaniga P,Gradilone A,Giuliani L. Expression and prognostic significance of LIVIN,SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer[J].Annals of Oncology,2003,(01):85-90.doi:10.1093/annonc/mdg002.
-
7Johnson M E,Howerth E W. Survivin:a bifunctional inhibitor of apoptosis protein[J].Veterinary Pathology,2004,(06):599-607.
-
8Sah N K,Khan Z,Khan G J. Structural,functional and therapeutic biology of survivin[J].Cancer Letters,2006,(02):164-171.doi:10.1016/j.canlet.2006.03.007.
-
9Loyer P,Trembley J H,Katona R. Role of CDK/cyclin complexes in transcription and RNA splicing[J].Cellular Signalling,2005,(09):1033-1051.
-
10Takizawa B T,Uchio E M,Cohen J J. Downregulation of survivin is associated with reductions in TNF receptors' mRNA and protein and alterations in nuclear factor kappa B signaling in urothelial cancer cells[J].Cancer Investigation,2007,(08):678-684.
-
1胡宏波,罗春丽.膀胱肿瘤动物模型研究进展[J].国际检验医学杂志,2004,26(5):426-428. 被引量：7
-
2万丽,任雨,吴秀玲.VEGF、survivin、bcl-2在膀胱移行细胞癌中的表达和意义[J].临床与实验病理学杂志,2007,23(4):512-512. 被引量：2
-
3朱熹,胡晓舟,马麟麟,田野.泌尿系移行细胞癌患者外周血CD4＋CD25highCD127low/-调节性T细胞的水平及意义[J].中华医学杂志,2009,89(32):2269-2272. 被引量：5
-
4宋华,孙颖浩,许传亮,周铁,孟建中.膀胱移行细胞癌中促红细胞生成素及其受体的表达[J].临床与实验病理学杂志,2007,23(4):453-456. 被引量：3
-
5梁雪峰,丁震宇,谢晓冬.细胞因子诱导的杀伤细胞在肿瘤治疗中的作用[J].国际肿瘤学杂志,2012,39(5):344-347. 被引量：6
-
6姜俭,白岚,梁玉,任怡敏,许屏,张宰昌,殷平.7690-Xu荧光染色法在泌尿系统疾病的应用研究[J].天津医科大学学报,2000,6(4):386-388.
-
7余志贤,夏同礼,薛兆英.膀胱乳头状移行细胞癌中高危人乳头瘤病毒的检测[J].中华外科杂志,1999,37(6):369-371. 被引量：1
-
8千日成,狄文,nao suzuki.第二届上海生育力保存论坛--暨亚洲生育力保存学会研讨会[J].中华生殖与避孕杂志,2017,37(3):187-187.
-
9姚娟,李永平.肿瘤基因治疗的应用及挑战[J].分子诊断与治疗杂志,2011,3(1):68-72. 被引量：3
-
10颜汝平,王剑松,李翀,杨德林,谢蜀生,徐鸿毅.荷人膀胱癌原位移植瘤Balb/c裸小鼠动物模型的建立[J].云南医药,2005,26(3):190-193. 被引量：4
